HIV Co-Receptor Tropism (Trofile) Assay
Nervous System/Brain Cancer Panel, NGS
Carboxy-Tetrahydrocannabinol (THC) Metabolite, Serum or Plasma, Quantitative
Germ Cell Tumor (GCT), Isochromosome 12p, FISH, Tissue
Carcinoembryonic Antigen (CEA), Cerebrospinal Fluid
Basic Metabolic Panel (BMP)
Neurofibromatosis Type 2 (NF2) Gene Mutation Analysis
Acetylcholinesterase (AChE), Blood
Ataxia telangiectasia
5-Hydroxyindoleacetic Acid (5-HIAA), Urine
LDS
Sign up
Log in
LDS
/
Medical Tests
/
BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test
CPT
Access to
BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
is restricted.
Sign up now